harmacare
Discussion & Debate
Access, Value, and Reform: An Analysis of Canada’s Pharmaceutical Policy Framework
Douglas Clark
Data Matters
Medicine List for Public Funding From Existing Lists
Ronan Murphy, Amal Rizvi, Moizza Zia Ul Haq and Nav Persaud
Discussion and Debate
Commentary: Which Principles Should Apply for a National Strategy on Rare Diseases?
Marc-André Gagnon
Research Paper
Conflicts of Interest of Canadian Medical School Deans: A Cross-Sectional Study
Joel Lexchin
Discussion and Debate
Federal Funding for Expensive Drugs for Rare Diseases: How Do We Pick and Choose?
Joel Lexchin and Sandra Sirrs
Discussion and Debate
Commentary: The Conflict Between Protecting Public Health and Raising Tax Revenue
Wayne Hall
Discussion and Debate
Five Years After Cannabis Legalization, Is It Time to Ease Restrictions on Promotion?
Jean-François Crépault, Sergio Rueda and Victor Tang
Research Paper
Methadone Prescribing Regulation for Opioid Use Disorder in Canada: Evidence for an East–West Policy Divide
Chloe Campbell, Kellia Chiu and Abhimanyu Sud